Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Agenus Inc (NASDAQ:AGEN)

8.54
Delayed Data
As of Jul 31
 +0.15 / +1.79%
Today’s Change
2.56
Today|||52-Week Range
10.16
+115.11%
Year-to-Date

Today’s Trading

Previous close8.39
Today’s open8.40
Day’s range8.27 - 8.69
Volume686,882
Average volume (3 months)1,703,892
Market cap$704.6M
Dividend yield--
Data as of 3:59pm ET, 07/31/2015

Growth & Valuation

Earnings growth (last year)+36.61%
Earnings growth (this year)-29.81%
Earnings growth (next 5 years)+1.00%
Revenue growth (last year)+129.13%
P/E ratioNM
Price/Sales34.00
Price/Book23.27

Competitors

 Today’s
change
Today’s
% change
FMIFoundation Medicine ...-2.00-8.99%
BPMCBlueprint Medicines ...+0.48+1.81%
OSIROsiris Therapeutics ...+0.28+1.33%
OVASOvaScience Inc+0.35+1.24%
Data as of 3:59pm ET, 07/31/2015

Financials

Next reporting dateOctober 29, 2015
EPS forecast (this quarter)-$0.10
Annual revenue (last year)$7.0M
Annual profit (last year)-$42.5M
Net profit margin-608.91%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Garo H. Armen
Chief Financial Officer
Charles Evan Ballantyne
Corporate headquarters
Lexington, Massachusetts

Forecasts